General Prestige Class: Geomancer. The cleric reaches out to a higher power. The wizard trusts only in eldritch tomes. The druid looks to nature for her spells. To the geomancer, however, all magic is the same. Geomancy is the art of channeling magical energy from many sources through the land itself. Home Networking, Home Security, Home Automation. For Business. Business networking, data storage, IP cameras. D amp d 3 5 players handbook ii oef pdf From 4shared.com (20 MB) Download d d players handbook 3.5 pdf files found Uploaded on TraDownload and all major free file sharing websites like 4shared.com, uploaded.to, mediafire.com and many others.

1. D And D 3.5 Classes
2. D And D 3.5 Races
3. D&d 3.5 Handbook Pdf
4. D& D 3.5 Geomancer Handbook Pdf
5. D And D 3.5 Players Handbook Pdf

D & L PARTS COMPANY, INC. (formerly known as D&L Appliance Parts Company, Inc.) is an American, Family-Owned business serving the Southeast since 1955. We are a wholesale distributor of parts, supplies, and equipment for major appliances, refrigeration, and heating and air conditioning systems. Ley Lines: At 2nd level, the geomancer learns to create magical connections with a specific type of terrain. Choose one of the following terrain types: aquatic, desert, forest, hills, marsh, mountains, or plains. In that terrain, the geomancer’s effective caster level for all spells increases by +1. My take on the FFT geomancer. It's really pretty open to critique, as I didn't really bounce ideas off of anyone for this one. Dungeons and Dragons Wiki.

Vitamin D is a group of fat-soluble secosteroids responsible for increasing intestinal absorption of calcium, magnesium, and phosphate, and multiple other biological effects.^[1] In humans, the most important compounds in this group are vitamin D₃ (also known as cholecalciferol) and vitamin D₂ (ergocalciferol).^[2]

The major natural source of the vitamin is synthesis of cholecalciferol in the skin from cholesterol through a chemical reaction that is dependent on sun exposure (specifically UVB radiation).^[3][4] Cholecalciferol and ergocalciferol can be ingested from the diet and from supplements.^[2][5][6] Only a few foods, such as the flesh of fatty fish, contain significant amounts of vitamin D, and fish does not contain enough vitamin D to achieve optimal Vitamin D status without sunlight or supplements.^[7][8] Dietary recommendations typically assume that all of a person's vitamin D is taken by mouth, as sun exposure in the population is variable and recommendations about the amount of sun exposure that is safe are uncertain in view of the skin cancer risk.^[7]

Vitamin D from the diet, or from skin synthesis, is biologically inactive. A protein enzyme must hydroxylate it to convert it to the active form. This is done in the liver and in the kidneys. As vitamin D can be synthesized in adequate amounts by most mammals exposed to sufficient sunlight, it is not an essential dietary factor, and so not technically a vitamin.^[6] Instead it could be considered a hormone, with activation of the vitamin D pro-hormone resulting in the active form, calcitriol, which then produces effects via a nuclear receptor in multiple locations.^[6]

Cholecalciferol is converted in the liver to calcifediol (25-hydroxycholecalciferol); ergocalciferol is converted to 25-hydroxyergocalciferol. These two vitamin D metabolites (called 25-hydroxyvitamin D or 25(OH)D) are measured in serum to determine a person's vitamin D status.^[9][10] Calcifediol is further hydroxylated by the kidneys to form calcitriol (also known as 1,25-dihydroxycholecalciferol), the biologically active form of vitamin D.^[11] Calcitriol circulates as a hormone in the blood, having a major role regulating the concentration of calcium and phosphate, and promoting the healthy growth and remodeling of bone. Calcitriol also has other effects, including some on cell growth, neuromuscular and immune functions, and reduction of inflammation.^[7]

Vitamin D has a significant role in calcium homeostasis and metabolism. Its discovery was due to effort to find the dietary substance lacking in children with rickets (the childhood form of osteomalacia).^[12] Vitamin D supplements are given to treat or to prevent osteomalacia and rickets, but the evidence for other health effects of vitamin D supplementation in the general population is inconsistent.^[13][14] The effect of vitamin D supplementation on mortality is not clear, with one meta-analysis finding a small decrease in mortality in elderly people,^[15] and another concluding no clear justification exists for recommending supplementation for preventing many diseases, and that further research of similar design is unneeded in these areas.^[16]

• 3Deficiency
  • 3.1Bone health
• 4Use of supplements
  • 4.5Immune system
• 5Dietary intake
  • 5.1Recommended levels
  • 5.2Sources
• 7Excess
• 8Biosynthesis
• 9Mechanism of action

Types[edit]

Several forms (vitamers) of vitamin D exist. The two major forms are vitamin D₂ or ergocalciferol, and vitamin D₃ or cholecalciferol; vitamin D without a subscript refers to either D₂ or D₃ or both. These are known collectively as calciferol.^[17] Vitamin D₂ was chemically characterized in 1931. In 1935, the chemical structure of vitamin D₃ was established and proven to result from the ultraviolet irradiation of 7-dehydrocholesterol.^[18]

Chemically, the various forms of vitamin D are secosteroids, i.e., steroids in which one of the bonds in the steroid rings is broken.^[18] The structural difference between vitamin D₂ and vitamin D₃ is the side chain of D₂ contains a double bond between carbons 22 and 23, and a methyl group on carbon 24.

Biology[edit]

The active vitamin D metabolite calcitriol mediates its biological effects by binding to the vitamin D receptor (VDR), which is principally located in the nuclei of target cells.^[18] The binding of calcitriol to the VDR allows the VDR to act as a transcription factor that modulates the gene expression of transport proteins (such as TRPV6 and calbindin), which are involved in calcium absorption in the intestine.^[20] The vitamin D receptor belongs to the nuclear receptor superfamily of steroid/thyroid hormone receptors, and VDRs are expressed by cells in most organs, including the brain, heart, skin, gonads, prostate, and breast.

VDR activation in the intestine, bone, kidney, and parathyroid gland cells leads to the maintenance of calcium and phosphorus levels in the blood (with the assistance of parathyroid hormone and calcitonin) and to the maintenance of bone content.^[1]

One of the most important roles of vitamin D is to maintain skeletal calcium balance by promoting calcium absorption in the intestines, promoting bone resorption by increasing osteoclast number, maintaining calcium and phosphate levels for bone formation, and allowing proper functioning of parathyroid hormone to maintain serum calcium levels. Vitamin D deficiency can result in lower bone mineral density and an increased risk of reduced bone density (osteoporosis) or bone fracture because a lack of vitamin D alters mineral metabolism in the body.^[21] Thus, vitamin D is also critical for bone remodeling through its role as a potent stimulator of bone resorption.^[21]

The VDR regulates cell proliferation and differentiation. Vitamin D also affects the immune system, and VDRs are expressed in several white blood cells, including monocytes and activated T and B cells.^[22] In vitro, vitamin D increases expression of the tyrosine hydroxylase gene in adrenalmedullary cells, and affects the synthesis of neurotrophic factors, nitric oxide synthase, and glutathione.^[23]

Deficiency[edit]

A diet with insufficient vitamin D in conjunction with inadequate sun exposure causes vitamin D deficiency. Severe vitamin D deficiency in children causes rickets, a softening and weakening of bones, which is a rare disease in the developed world.^[24] Vitamin D deficiency is found worldwide in the elderly and remains common in children and adults.^[25][26][27] Deficiency results in impaired bone mineralization and bone damage which leads to bone-softening diseases,^[28] including rickets in children and osteomalacia in adults. Low blood calcifediol (25-hydroxy-vitamin D) can result from avoiding the sun.^[29] Being deficient in vitamin D can cause intestinal absorption of dietary calcium to fall to 15%.^[1] When not deficient, an individual usually absorbs between 60-80%.^[1]

Bone health[edit]

Rickets[edit]

Rickets, a childhood disease, is characterized by impeded growth and soft, weak, deformed long bones that bend and bow under their weight as children start to walk. This condition is characterized by bow legs,^[28] which can be caused by calcium or phosphorus deficiency, as well as a lack of vitamin D; today, it is largely found in low-income countries in Africa, Asia, or the Middle East^[30] and in those with genetic disorders such as pseudovitamin D deficiency rickets.^[31]

Maternal vitamin D deficiency may cause overt bone disease from before birth and impairment of bone quality after birth.^[32][33] Nutritional rickets exists in countries with intense year-round sunlight such as Nigeria and can occur without vitamin D deficiency.^[34][35]

Although rickets and osteomalacia are now rare in the UK, outbreaks have happened in some immigrant communities in which osteomalacia sufferers included women with seemingly adequate daylight outdoor exposure wearing Western clothing.^[36] Having darker skin and reduced exposure to sunshine did not produce rickets unless the diet deviated from a Western omnivore pattern characterized by high intakes of meat, fish, and eggs, and low intakes of high-extraction cereals.^[37][38][39] The dietary risk factors for rickets include abstaining from animal foods.^[36][40]

Vitamin D deficiency remains the main cause of rickets among young infants in most countries, because breast milk is low in vitamin D and social customs and climatic conditions can prevent adequate sun exposure. In sunny countries such as Nigeria, South Africa, and Bangladesh, where rickets occurs among older toddlers and children, it has been attributed to low dietary calcium intakes, which are characteristic of cereal-based diets with limited access to dairy products.^[39]

Rickets was formerly a major public health problem among the US population; in Denver, where ultraviolet rays are about 20% stronger than at sea level on the same latitude,^[41] almost two-thirds of 500 children had mild rickets in the late 1920s.^[42] An increase in the proportion of animal protein^[40][43] in the 20th century American diet coupled with increased consumption of milk^[44][45] fortified with relatively small quantities of vitamin D coincided with a dramatic decline in the number of rickets cases.^[1] Also, in the United States and Canada, vitamin D-fortified milk, infant vitamin supplements, and vitamin supplements have helped to eradicate the majority of cases of rickets for children with fat malabsorption conditions.^[28]

Osteoporosis and osteomalacia[edit]

Osteomalacia is a disease in adults that results from vitamin D deficiency. Characteristics of this disease are softening of the bones, leading to bending of the spine, bowing of the legs, proximal muscle weakness, bone fragility, and increased risk for fractures.^[46] Osteomalacia reduces calcium absorption and increases calcium loss from bone, which increases the risk for bone fractures. Osteomalacia is usually present when 25-hydroxyvitamin D levels are less than about 10ng/mL.^[2] Although the effects of osteomalacia are thought to contribute to chronic musculoskeletalpain,^[47] there is no persuasive evidence of lower vitamin D levels in chronic pain sufferers^[48] or that supplementation alleviates chronic nonspecific musculoskeletal pain.^[49]

Skin pigmentation[edit]

Dark-skinned people living in temperate climates have been shown to have low vitamin D levels but the significance of this is not certain.^[50][51][52] Dark-skinned people are less efficient at making vitamin D because melanin in the skin hinders vitamin D synthesis.^[53]

Non-bone diseases[edit]

Mortality, all cause[edit]

Use of supplements[edit]

The effects of vitamin D supplementation on health are uncertain.^[14][54] A 2013 review did not find any effect from supplementation on the rates of disease, other than a tentative decrease in mortality in the elderly.^[55] Vitamin D supplements do not alter the outcomes for myocardial infarction, stroke or cerebrovascular disease, cancer, bone fractures or knee osteoarthritis.^[16][56] Low vitamin D levels may result from disease rather than cause disease.^[55]

A United States Institute of Medicine report states: 'Outcomes related to cancer, cardiovascular disease and hypertension, and diabetes and metabolic syndrome, falls and physical performance, immune functioning and autoimmune disorders, infections, neuropsychological functioning, and preeclampsia could not be linked reliably with calcium or vitamin D intake and were often conflicting.'^[57]:5 Some researchers claim the IOM was too definitive in its recommendations and made a mathematical mistake when calculating the blood level of vitamin D associated with bone health.^[58] Members of the IOM panel maintain that they used a 'standard procedure for dietary recommendations' and that the report is solidly based on the data. Research on vitamin D supplements, including large-scale clinical trials, is continuing.^[58]

Mortality, all-cause[edit]

Vitamin D₃ supplementation has been tentatively found to lead to a reduced risk of death in the elderly,^[15][55] but the effect has not been deemed pronounced, or certain enough, to make taking supplements recommendable.^[16] Other forms (vitamin D₂, alfacalcidol, and calcitriol) do not appear to have any beneficial effects with regard to the risk of death.^[15] High blood levels appear to be associated with a lower risk of death, but it is unclear if supplementation can result in this benefit.^[59] Both an excess and a deficiency in vitamin D appear to cause abnormal functioning and premature aging.^[60][61][62] The relationship between serum calcifediol level and all-cause mortality is parabolic.^[57] Harm from vitamin D appears to occur at a lower vitamin D level in the black population than in the white population.^[57]:435

Bone health[edit]

In general, no good evidence supports the commonly held belief that vitamin D supplements can help prevent osteoporosis.^[16] Its general use for prevention of this disease in those without vitamin D deficiency is thus likely not needed.^[63] For older people with osteoporosis, taking vitamin D with calcium may help prevent hip fractures, but it also slightly increases the risk of stomach and kidney problems.^[64] Supplementation with higher doses of vitamin D, in those older than 65 years, may decrease fracture risk.^[65] The effect is small or none for people living independently.^[66][67] Low serum vitamin D levels have been associated with falls, and low bone mineral density.^[68] Taking extra vitamin D, however, does not appear to change the risk.^[69] Athletes who are vitamin D deficient are at an increased risk of stress fractures and/or major breaks, particularly those engaging in contact sports. The greatest benefit with supplementation is seen in athletes who are deficient (25(OH)D serum levels <30ng/mL), or severely deficient (25(OH)D serum levels <25ng/mL). Incremental decreases in risks are observed with rising serum 25(OH)D concentrations plateauing at 50ng/mL with no additional benefits seen in levels beyond this point.^[70]

Because it found mounting evidence for a benefit to bone health, though it had not found good evidence of other benefits, the US Food and Drug Administration (FDA) has required manufacturers to declare the amount of vitamin D on nutrition facts labels, as 'nutrients of public health significance', since May 2016. By a proposed deadline extension, small manufacturers with less than $10million in annual food sales will have to comply by January 1, 2021, while larger ones have to comply by January 1, 2020.^[71] Manufacturers of single-ingredient sugars such as honey and maple syrup and certain cranberry products have until July 1, 2021, to make the changes.^[71]

Cancer[edit]

Vitamin D supplements have been widely marketed for their claimed anticancer properties.^[72] Associations have been shown in observational studies between low vitamin D levels and the risk of development of certain cancers.^[73] It is unclear, however, if taking additional vitamin D in the diet or as supplements affects the risk of cancer. Reviews have described the evidence as being 'inconsistent, inconclusive as to causality, and insufficient to inform nutritional requirements'^[57] and 'not sufficiently robust to draw conclusions'.^[66] One 2014 review found that supplements had no significant effect on cancer risk.^[16]

Another 2014 review concluded that vitamin D₃ may decrease the risk of death from cancer (one fewer death in 150 people treated over 5 years), but concerns with the quality of the data were noted.^[15] Insufficient evidence exists to recommend vitamin D supplements for people with cancer, although some evidence suggests that low vitamin D may be associated with a worse outcome for some cancers,^[74] and that higher 25-hydroxy vitamin D levels at the time of diagnosis are associated with better outcomes.^[75]

Cardiovascular disease[edit]

Taking vitamin D supplements does not meaningfully reduce the risk of stroke, cerebrovascular disease, cardial infarction, or ischemic heart disease.^[16][76] Supplementation may have no effect on blood pressure.^[77]

Immune system[edit]

Infectious diseases[edit]

In general, vitamin D functions to activate the innate and dampen the adaptive immune systems.^[78] Deficiency has been linked to increased risk or severity of viral infections, including HIV.^[79][80] Low levels of vitamin D appear to be a risk factor for tuberculosis,^[81] and historically it was used as a treatment.^[82] Supplementation slightly decreases the risk of acute respiratory tract infections and the exacerbation of asthma.^[83][84][85] Evidence is lacking on whether it does so in children under five years of age.^[86] No clinical trials have been done to assess its effect on preventing other infections, such as malaria.

Autoimmune diseases[edit]

Although tentative data link low levels of vitamin D to asthma, evidence to support a beneficial effect on asthmatics from supplementation is inconclusive.^[87] Accordingly, supplementation is not currently recommended for treatment or prevention of asthma.^[88] Vitamin D and multiple sclerosis incidence have been linked, but it is not clear what the nature of any causal relationship might be.^[89] Two systemic reviews concluded that the evidence for vitamin D supplementation being helpful for treating people with multiple sclerosis is inconclusive.^[90][91]

Inflammatory bowel disease[edit]

Low levels of vitamin D are associated with two major forms of human Inflammatory bowel disease (IBD): Crohn's disease and ulcerative colitis.^[92] However, further studies are required to determine its significance and the potential role of vitamin D axis in IBD.^[92][93]

Other conditions[edit]

Diabetes -- A systematic review of 2014 concluded that the available studies show no evidence of vitamin D3 supplementation having an effect on glucose homeostasis or diabetes prevention.^[94] A review article of 2016 reported that while there is increasing evidence that vitamin D deficiency may be a risk factor for diabetes, over-all evidence regarding vitamin D levels and diabetes mellitus is contradictory, requiring further studies.^[95]

Depression -- Clinical trials of vitamin D supplementation for depressive symptoms have generally been of low quality and show no overall effect, although subgroup analysis showed supplementation for participants with clinically significant depressive symptoms or depressive disorder had a moderate effect.^[96]

Cognition and dementia -- A systematic review of clinical studies found an association between low vitamin D levels with cognitive impairment and a higher risk of developing Alzheimer's disease. However, lower vitamin D concentrations are also associated with poor nutrition and spending less time outdoors. Therefore, alternative explanations for the increase in cognitive impairment exist and hence a direct causal relationship between vitamin D levels and cognition could not be established.^[97]

Pregnancy -- Low levels of vitamin D in pregnancy are associated with gestational diabetes, pre-eclampsia, and small (for gestational age) infants.^[98] Although taking vitamin D supplements during pregnancy raises blood levels of vitamin D in the mother at term,^[99] the extent of benefits for the mother or baby is unclear.^{[98][99][100]} Pregnant women who take an adequate amount of vitamin D during gestation may experience a lower risk of pre-eclampsia^[99] and positive immune effects.^[101] A 2018 review found that supplements may reduce the risk of undersized babies and of their poor rate of growth.^[102] Pregnant women often do not take the recommended amount of vitamin D.^[101]

Weight loss -- Though hypothesized that vitamin D supplementation may be an effective treatment for obesity apart from calorie restriction, one systematic review found no association of supplementation with body weight or fat mass.^[103] A 2016 meta-analysis found that circulating vitamin D status was improved by weight loss, indicating that fat mass may be inversely associated with blood levels of vitamin D.^[104]

Allowable health claims[edit]

Governmental regulatory agencies stipulate for the food and dietary supplement industries certain health claims as allowable as statements on packaging.

• normal function of the immune system^[105]
• normal inflammatory response^[105]
• normal muscle function^[105]
• reduced risk of falling in people over age 60^[106]

US Food and Drug Administration (FDA)

• 'Adequate calcium and vitamin D, as part of a well balanced diet, along with physical activity, may reduce the risk of osteoporosis.'^[107]

• Adequate calcium and regular exercise may help to achieve strong bones in children and adolescents and may reduce the risk of osteoporosis in older adults. An adequate intake of vitamin D is also necessary^[108]

Other possible agencies with claim guidance: Japan FOSHU^[109] and Australia-New Zealand.^[110]

Dietary intake[edit]

Recommended levels[edit]

Conversion: 1µg = 40IU.

Various institutions have proposed different recommendations for the amount of daily intake of vitamin D. These vary according to precise definition, age, pregnancy or lactation, and the extent assumptions are made regarding skin synthesis of vitamin D.^{[57][111][112][113]}

United States[edit]

The dietary reference intake for vitamin D issued in 2010 by the Institute of Medicine (IoM) (renamed National Academy of Medicine in 2015), superseded previous recommendations which were expressed in terms of Adequate Intake. The recommendations were formed assuming the individual has no skin synthesis of vitamin D because of inadequate sun exposure. The reference intake for vitamin D refers to total intake from food, beverages and supplements, and assumes that calcium requirements are being met.^[57]:5 The tolerable upper intake level (UL) is defined as 'the highest average daily intake of a nutrient that is likely to pose no risk of adverse health effects for nearly all persons in the general population.'^[57]:403 Although ULs are believed to be safe, information on the long-term effects is incomplete and these levels of intake are not recommended for long-term consumption.^[57]:403:433

For U.S food and dietary supplement labeling purposes, the amount in a serving is expressed as a percent of Daily Value (%DV). For vitamin D labeling purposes, 100% of the Daily Value was 400IU (10μg), but on May 27, 2016, it was revised to 800IU (20μg) to bring it into agreement with the RDA.^[115] The deadline to be in compliance was extended to January 1, 2020 for large companies and January 1, 2021 for small companies.^[71]

Canada[edit]

Health Canada published recommended dietary allowances (RDA) and tolerable upper intake levels for vitamin D in 2012^[111] based on the Institute of Medicine report.^[57]

Australia and New Zealand[edit]

Australia and New Zealand published nutrient reference values including guidelines for dietary vitamin D intake in 2005.^[112] About a third of Australians have vitamin D deficiency.^[116]

European Union[edit]

The European Food Safety Authority (EFSA) in 2016^[113] reviewed the current evidence, finding the relationship between serum 25(OH)D concentration and musculoskeletal health outcomes is widely variable. They considered that average requirements and population reference intakes values for vitamin D cannot be derived, and that a serum 25(OH)D concentration of 50nmol/L was a suitable target value. For all people over the age of 1, including women who are pregnant or lactating, they set an adequate intake of 15μg/day (600IU).^[113]

The EFSA reviewed safe levels of intake in 2012,^[114] setting the tolerable upper limit for adults at 100μg/day (4000IU), a similar conclusion as the IOM.

The UK National Health Service recommends babies and young children aged six months to five years, pregnant or breastfeeding women, and sun-deprived elderly people should take daily vitamin supplements to ensure sufficient vitamin D intake.^[117] In July 2016, Public Health England recommended that everyone consider taking a daily supplement containing 10µg of vitamin D during autumn and winter because of inadequate sunlight for vitamin D synthesis.^[118]

The Swedish National Food Agency recommends a daily intake of 10μg (400IU) of vitamin D3 for children and adults up to 75 years, and 20μg (800IU) for adults 75 and older.^[119]

Non-government organisations in Europe have made their own recommendations. The German Society for Nutrition recommends 20µg.^[120] The European Menopause and Andropause Society recommends postmenopausal women consume15µg (600IU) until age 70, and 20µg (800IU) from age 71. This dose should be increased to 100µg (4,000IU) in some patients with very low vitamin D status or in case of co-morbid conditions.^[121]

Sources[edit]

Although vitamin D is not present naturally in most foods,^[2][6] it is commonly added as a fortification in manufactured foods. In some countries, staple foods are artificially fortified with vitamin D.^[122]

Natural sources[edit]

In general, vitamin D₂ is found in fungi and vitamin D₃ is found in animals.^[123][124] Vitamin D₂ is produced by ultraviolet irradiation of ergosterol found in many fungi. The vitamin D₂ content in mushrooms and Cladina arbuscula, a lichen, increase with exposure to ultraviolet light.^[125][126] This process is emulated by industrial ultraviolet lamps, concentrating vitamin D₂ levels to higher levels.^[124]

The United States Department of Agriculture reports D₂ and D₃ content combined in one value.

Food fortification[edit]

Manufactured foods fortified with vitamin D include some fruit juices and fruit juice drinks, meal replacementenergy bars, soy protein-based beverages, certain cheese and cheese products, flour products, infant formulas, many breakfast cereals, and milk.^[128][129]

In 2016 in the United States, the Food and Drug Administration (FDA) amended food additive regulations for milk fortification,^[130] stating that vitamin D₃ levels not exceed 42IU vitamin D per 100g (400IU per US quart) of dairy milk, 84IU of vitamin D₂ per 100g (800IU per quart) of plant milks, and 89IU per 100g (800IU per quart) in plant-based yogurts or in soy beverage products.^{[131][132][133]} Plant milks are defined as beverages made from soy, almond, rice, among other plant sources intended as alternatives to dairy milk.^{[citation needed]}

While some studies have found that vitamin D₃ raises 25(OH)D blood levels faster and remains active in the body longer,^[134][135] others contend that vitamin D₂ sources are equally bioavailable and effective as D₃ for raising and sustaining 25(OH)D.^{[124][136][137]}

Food preparation[edit]

Vitamin D content in typical foods is reduced variably by cooking. Boiled, fried and baked foods retained 69–89% of original vitamin D.^[138]

Recommended serum levels[edit]

Recommendations on recommended 25(OH)D serum levels vary across authorities, and vary based on factors like age.^[7] US labs generally report 25(OH)D levels in ng/mL.^{[citation needed]} Other countries often use nmol/L.^{[citation needed]} Oneng/mL is approximately equal to 2.5nmol/L.^{[citation needed]}

A 2014 review concluded that the most advantageous serum levels for 25(OH)D for all outcomes appeared to be close to 30ng/mL (75nmol/L).^[141] The optimal vitamin D levels are still controversial and another review concluded that ranges from 30 to 40ng/mL (75 to 100nmol/L) were to be recommended for athletes.^[142] Part of the controversy is because numerous studies have found differences in serum levels of 25(OH)D between ethnic groups; studies point to genetic as well as environmental reasons behind these variations.^[143] Supplementation to achieve these standard levels could cause harmful vascular calcification.^[52]

A 2012 meta-analysis showed that the risk of cardiovascular diseases increases when blood levels of vitamin D are lowest in a range of 8 to 24ng/mL (20 to 60nmol/L), although results among the studies analyzed were inconsistent.^[144]

In 2011 an IOM committee concluded a serum 25(OH)D level of 20ng/mL (50nmol/L) is needed for bone and overall health. The dietary reference intakes for vitamin D are chosen with a margin of safety and 'overshoot' the targeted serum value to ensure the specified levels of intake achieve the desired serum 25(OH)D levels in almost all persons. No contributions to serum 25(OH)D level are assumed from sun exposure and the recommendations are fully applicable to people with dark skin or negligible exposure to sunlight. The Institute found serum 25(OH)D concentrations above 30ng/mL (75nmol/L) are 'not consistently associated with increased benefit'. Serum 25(OH)D levels above 50ng/mL (125nmol/L) may be cause for concern. However, some people with serum 25(OH)D between 30 and 50ng/mL (75nmol/L-125nmol/L) will also have inadequate vitamin D.^[57]

Excess[edit]

Vitamin D toxicity is rare.^[27] It is caused by supplementing with high doses of vitamin D rather than sunlight. The threshold for vitamin D toxicity has not been established; however, according to some research, the tolerable upper intake level (UL) is 4,000 IU/day for ages 9–71^[145] (100µg/day), while other research concludes that, in healthy adults, sustained intake of more than 1250μg/day (50,000IU) can produce overt toxicity after several months and can increase serum 25-hydroxyvitamin D levels to 150ng/mL and greater.^[27][146] Those with certain medical conditions, such as primary hyperparathyroidism,^[147] are far more sensitive to vitamin D and develop hypercalcemia in response to any increase in vitamin D nutrition, while maternal hypercalcemia during pregnancy may increase fetal sensitivity to effects of vitamin D and lead to a syndrome of mental retardation and facial deformities.^[147][148]

A review published in 2015 noted that adverse effects have been reported only at 25(OH)D serum concentrations above 200nmol/L.^[142]

Published cases of toxicity involving hypercalcemia in which the vitamin D dose and the 25-hydroxy-vitamin D levels are known all involve an intake of ≥40,000IU (1,000μg) per day.^[147]

Pregnant or breastfeeding women should consult a doctor before taking a vitamin D supplement. The FDA advised manufacturers of liquid vitamin D supplements that droppers accompanying these products should be clearly and accurately marked for 400 international units (1IU is the biological equivalent of 25ng cholecalciferol/ergocalciferol). In addition, for products intended for infants, the FDA recommends the dropper hold no more than 400IU.^[149] For infants (birth to 12 months), the tolerable upper limit (maximum amount that can be tolerated without harm) is set at 25μg/day (1,000IU). One thousand micrograms per day in infants has produced toxicity within one month.^[146] After being commissioned by the Canadian and American governments, the Institute of Medicine (IOM) as of 30 November 2010, has increased the tolerable upper limit (UL) to 2,500IU per day for ages 1–3 years, 3,000IU per day for ages 4–8 years and 4,000IU per day for ages 9–71+ years (including pregnant or lactating women).^[145]

Calcitriol itself is auto-regulated in a negative feedback cycle, and is also affected by parathyroid hormone, fibroblast growth factor 23, cytokines, calcium, and phosphate.^[150]

Effect of excess[edit]

Vitamin D overdose causes hypercalcemia, which is a strong indication of vitamin D toxicity – this can be noted with an increase in urination and thirst. If hypercalcemia is not treated, it results in excess deposits of calcium in soft tissues and organs such as the kidneys, liver, and heart, resulting in pain and organ damage.^[27][28][46]

The main symptoms of vitamin D overdose which are those of hypercalcemia including anorexia, nausea, and vomiting. These may be followed by polyuria, polydipsia, weakness, insomnia, nervousness, pruritus and ultimately renal failure. Furthermore, proteinuria, urinary casts, azotemia, and metastatic calcification (especially in the kidneys) may develop.^[146] Other symptoms of vitamin D toxicity include mental retardation in young children, abnormal bone growth and formation, diarrhea, irritability, weight loss, and severe depression.^[27][46]

Vitamin D toxicity is treated by discontinuing vitamin D supplementation and restricting calcium intake. Kidney damage may be irreversible. Exposure to sunlight for extended periods of time does not normally cause vitamin D toxicity. The concentrations of vitamin D precursors produced in the skin reach an equilibrium, and any further vitamin D produced is degraded.^[147]

Biosynthesis[edit]

Synthesis of vitamin D in nature is dependent on the presence of UV radiation and subsequent activation in liver and in kidney. Many animals synthesize vitamin D₃ from 7-dehydrocholesterol, and many fungi synthesize vitamin D₂ from ergosterol.^[123][124]

Interactive pathway[edit]

Click on icon in lower right corner to open.Click on genes, proteins and metabolites below to link to respective articles.^{[§ 1]}

1. ^The interactive pathway map can be edited at WikiPathways: 'VitaminDSynthesis_WP1531'.

Photochemistry[edit]

The transformation that converts 7-dehydrocholesterol to vitamin D₃ occurs in two steps.^[151][152] First, 7-dehydrocholesterol is photolyzed by ultraviolet light in a 6-electron conrotatory ring-opening electrocyclic reaction; the product is previtaminD₃. Second, previtaminD₃ spontaneously isomerizes to vitaminD₃ (cholecalciferol) in an antarafacialsigmatropic [1,7] hydride shift. At room temperature, the transformation of previtaminD₃ to vitamin D₃ in an organic solvent takes about 12 days to complete. The conversion of previtaminD₃ to vitamin D₃ in the skin is about 10 times faster than in an organic solvent.^[153]

The conversion from ergosterol to vitamin D₂ follows a similar procedure, forming previtaminD₂ by photolysis, which isomerizes to vitamin D₂.^[154] The transformation of previtaminD₂ to vitamin D₂ in methanol has a rate comparable to that of previtaminD₃. The process is faster in white button mushrooms.^{[124](fig. 3)}

Synthesis in the skin[edit]

Vitamin D₃ is produced photochemically from 7-dehydrocholesterol in the skin of most vertebrate animals, including humans.^[155] The precursor of vitamin D₃, 7-dehydrocholesterol is produced in relatively large quantities. 7-Dehydrocholesterol reacts with UVB light at wavelengths of 290–315 nm.^[156] These wavelengths are present in sunlight, as well as in the light emitted by the UV lamps in tanning beds (which produce ultraviolet primarily in the UVA spectrum, but typically produce 4% to 10% of the total UV emissions as UVB). Exposure to light through windows is insufficient because glass almost completely blocks UVB light.^[157][158]

Adequate amounts of vitamin D can be produced with moderate sun exposure to the face, arms and legs, averaging 5–30 minutes twice per week, or approximately 25% of the time for minimal sunburn. The darker the skin, and the weaker the sunlight, the more minutes of exposure are needed. Vitamin D overdose is impossible from UV exposure; the skin reaches an equilibrium where the vitamin degrades as fast as it is created.^{[27][159][160]}

Sunscreen absorbs or reflects ultraviolet light and prevents much of it from reaching the skin.^[161] Sunscreen with a sun protection factor (SPF) of 8 based on the UVB spectrum decreases vitamin D synthetic capacity by 95%, and SPF 15 decreases it by 98%.^[57]

The skin consists of two primary layers: the inner layer called the dermis, composed largely of connective tissue, and the outer, thinner epidermis.^[162] Thick epidermis in the soles and palms consists of five strata; from outer to inner, they are: the stratum corneum, stratum lucidum, stratum granulosum, stratum spinosum, and stratum basale. Vitamin D is produced in the keratinocytes^[163] of two innermost strata, the stratum basale and stratum spinosum.^[161]

Evolution[edit]

Vitamin D can be synthesized only by a photochemical process. Phytoplankton in the ocean (such as coccolithophore and Emiliania huxleyi) have been photosynthesizing vitamin D for more than 500million years. Primitive vertebrates in the ocean could absorb calcium from the ocean into their skeletons and eat plankton rich in vitamin D.

Land vertebrates required another source of vitamin D other than plants for their calcified skeletons. They had to either ingest it or be exposed to sunlight to photosynthesize it in their skin.^[123][153] Land vertebrates have been photosynthesizing vitamin D for more than 350million years.^[164]

In birds and fur-bearing mammals, fur or feathers block UV rays from reaching the skin. Instead, vitamin D is created from oily secretions of the skin deposited onto the feathers or fur, and is obtained orally during grooming.^[165] However, some animals, such as the naked mole-rat, are naturally cholecalciferol-deficient, as serum 25-OH vitamin D levels are undetectable.^[166]

Industrial synthesis[edit]

Vitamin D₃ (cholecalciferol) is produced industrially by exposing 7-dehydrocholesterol to UVB light, followed by purification.^[167] The 7-dehydrocholesterol is a natural substance in fish organs, especially the liver,^[168] or in wool grease (lanolin) from sheep. Vitamin D₂ (ergocalciferol) is produced in a similar way using ergosterol from yeast or mushrooms as a starting material.^[167][124]

Mechanism of action[edit]

Metabolic activation[edit]

D And D 3.5 Classes

Vitamin D is carried in the bloodstream to the liver, where it is converted into the prohormonecalcifediol. Circulating calcifediol may then be converted into calcitriol, the biologically active form of vitamin D, in the kidneys.^[169]

Whether it is made in the skin or ingested, vitamin D is hydroxylated in the liver at position 25 (upper right of the molecule) to form 25-hydroxycholecalciferol (calcifediol or 25(OH)D).^[170] This reaction is catalyzed by the microsomal enzyme vitamin D 25-hydroxylase, the product of the CYP2R1 human gene, and expressed by hepatocytes.^[171] Once made, the product is released into the plasma, where it is bound to an α-globulin carrier protein named the vitamin D-binding protein.^[172]

Calcifediol is transported to the proximal tubules of the kidneys, where it is hydroxylated at the 1-α position (lower right of the molecule) to form calcitriol (1,25-dihydroxycholecalciferol, 1,25(OH)₂D). The conversion of calcifediol to calcitriol is catalyzed by the enzyme 25-hydroxyvitamin D₃ 1-alpha-hydroxylase, which is the product of the CYP27B1 human gene. The activity of CYP27B1 is increased by parathyroid hormone, and also by low calcium or phosphate.^[6][169]

Following the final converting step in the kidney, calcitriol is released into the circulation. By binding to vitamin D-binding protein, calcitriol is transported throughout the body, including to the classical target organs of intestine, kidney and bone.^[18] Calcitriol is the most potent natural ligand of the vitamin D receptor, which mediates most of the physiological actions of vitamin D.^[6][169]

In addition to the kidneys, calcitriol is also synthesized by certain other cells including monocyte-macrophages in the immune system. When synthesized by monocyte-macrophages, calcitriol acts locally as a cytokine, modulating body defenses against microbial invaders by stimulating the innate immune system.^[169]

Inactivation[edit]

The activity of calcifediol and calcitriol can be reduced by hydroxylation at position 24 by vitamin D3 24-hydroxylase, forming secalciferol and calcitetrol, respectively.^[170]

Difference between substrates[edit]

VitaminD₂ (ergocalciferol) and vitaminD₃ (cholecaliferol) share a similar mechanism of action as outlined above.^[170] Metabolites produced by vitamin D₂ are sometimes named with an er- or ergo prefix to differentiate them from the D₃-based counterparts.^[173]

• Metabolites produced from vitaminD₂ tend to bind less well to the vitamin D-binding protein.
• VitaminD₃ can alternatively be hydroxylated to calcifediol by sterol 27-hydroxylase (CYP27A1), but vitaminD₂ cannot.
• Ergocalciferol can be directly hydroxylated at position 24. This hydroxylation also leads to a greater degree of inactivation: while calcitriol's activity decreases to 60% of original after 24-hydroxylation, ^[174] ercalcitriol suffers a 10-fold decrease in activity on conversion to ercalcitetrol.^[175]

History[edit]

American researchers Elmer McCollum and Marguerite Davis in 1914^[12] discovered a substance in cod liver oil which later was called 'vitamin A'. British doctor Edward Mellanby noticed dogs that were fed cod liver oil did not develop rickets and concluded vitamin A, or a closely associated factor, could prevent the disease. In 1922, Elmer McCollum tested modified cod liver oil in which the vitamin A had been destroyed.^[12] The modified oil cured the sick dogs, so McCollum concluded the factor in cod liver oil which cured rickets was distinct from vitamin A. He called it vitamin D because it was the fourth vitamin to be named.^{[176][177][178]} It was not initially realized that, unlike other vitamins, vitamin D can be synthesised by humans through exposure to UV light.

In 1925,^[12] it was established that when 7-dehydrocholesterol is irradiated with light, a form of a fat-soluble vitamin is produced (now known as D₃). Alfred Fabian Hess stated: 'Light equals vitamin D.'^[179]Adolf Windaus, at the University of Göttingen in Germany, received the Nobel Prize in Chemistry in 1928 for his work on the constitution of sterols and their connection with vitamins.^[180] In 1929, a group at NIMR in Hampstead, London, were working on the structure of vitamin D, which was still unknown, as well as the structure of steroids. A meeting took place with J.B.S. Haldane, J.D. Bernal, and Dorothy Crowfoot to discuss possible structures, which contributed to bringing a team together. X-ray crystallography demonstrated the sterol molecules were flat, not as proposed by the German team led by Windaus. In 1932, Otto Rosenheim and Harold King published a paper putting forward structures for sterols and bile acids which found immediate acceptance.^[181] The informal academic collaboration between the team members Robert Benedict Bourdillon, Otto Rosenheim, Harold King, and Kenneth Callow was very productive and led to the isolation and characterization of vitamin D.^[182] At this time, the policy of the Medical Research Council was not to patent discoveries, believing the results of medical research should be open to everybody. In the 1930s, Windaus clarified further the chemical structure of vitamin D.^[183]

In 1923, American biochemist Harry Steenbock at the University of Wisconsin demonstrated that irradiation by ultraviolet light increased the vitamin D content of foods and other organic materials.^[184] After irradiating rodent food, Steenbock discovered the rodents were cured of rickets. A vitamin D deficiency is a known cause of rickets. Using $300 of his own money, Steenbock patented his invention. His irradiation technique was used for foodstuffs, most memorably for milk. By the expiration of his patent in 1945, rickets had been all but eliminated in the US.^[185]

In 1969, after studying nuclear fragments of intestinal cells, a specific binding protein for vitamin D called the vitamin D receptor was identified by Mark Haussler and Tony Norman.^[186] In 1971–72, the further metabolism of vitamin D to active forms was discovered. In the liver, vitamin D was found to be converted to calcifediol. Calcifediol is then converted by the kidneys to calcitriol, the biologically active form of vitamin D.^[11] Calcitriol circulates as a hormone in the blood, regulating the concentration of calcium and phosphate in the bloodstream and promoting the healthy growth and remodeling of bone. The vitamin D metabolites, calcifediol and calcitriol, were identified by competing teams led by Michael F. Holick in the laboratory of Hector DeLuca and by Tony Norman and colleagues.^{[187][188][189]}

Research[edit]

There is considerable research activity looking at effects of vitamin D and its metabolites in animal models, cell systems, gene expression studies, epidemiology and clinical therapeutics. These different types of studies can produce conflicting evidence as to the benefits of interventions with vitamin D.^[190] One school of thought contends the human physiology is fine-tuned to an intake of 4,000–12,000IU/day from sun exposure with concomitant serum 25-hydroxyvitamin D levels of 40 to 80ng/mL^[191] and this is required for optimal health. Proponents of this view, who include some members of the panel that drafted a now-superseded 1997 report on vitamin D from the IOM, contend the IOM's warning about serum concentrations above 50ng/mL lacks biological plausibility. They suggest, for some people, reducing the risk of preventable disease requires a higher level of vitamin D than that recommended by the IOM.^[191][192]

The United States National Institutes of Health Office of Dietary Supplements established a Vitamin D Initiative in 2014 to track current research and provide education to consumers.^[193] In their 2016 review, they recognize that a growing body of research suggests that vitamin D might play some role in the prevention and treatment of types 1 and 2 diabetes, glucose intolerance, hypertension, multiple sclerosis, and other medical conditions. They state further: 'however, most evidence for these roles comes from in vitro, animal, and epidemiological studies, not the randomized clinical trials considered to be more definitive. Until such trials are conducted, the implications of the available evidence for public health and patient care will be debated'.^[7]

D And D 3.5 Races

Some preliminary studies link low vitamin D levels with disease later in life.^[194] Evidence as of 2013 is insufficient to determine whether vitamin D affects the risk of cancer.^[195]One meta-analysis found a decrease in mortality in elderly people.^[15] Another meta-analysis covering over 350,000 people concluded that vitamin D supplementation in unselected community-dwelling individuals does not reduce skeletal (total fracture) or non-skeletal outcomes (myocardial infarction, ischemic heart disease, stroke, cerebrovascular disease, cancer) by more than 15%, and that further research trials with similar design are unlikely to change these conclusions.^[16] A 2019 meta-analysis found that there may be an increased risk of stroke when taking both calcium and vitamin D.^[196]

Vitamin D deficiency is widespread in the European population.^[197] European research is assessing vitamin D intake levels in association with disease rates and policies of dietary recommendations, food fortification, vitamin D supplementation, and small amounts of sun exposure.^[129]

Apart from VDR activation, various alternative mechanisms of action are under study, such as inhibition of signal transduction by hedgehog, a hormone involved in morphogenesis.^[198]

References[edit]

1. ^ ^abcdeHolick MF (December 2004). 'Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease'. The American Journal of Clinical Nutrition. 80 (6 Suppl): 1678S–88S. doi:10.1093/ajcn/80.6.1678S. PMID15585788.
2. ^ ^abcdHolick MF (March 2006). 'High prevalence of vitamin D inadequacy and implications for health'. Mayo Clinic Proceedings. 81 (3): 353–73. doi:10.4065/81.3.353. PMID16529140.
3. ^MacDonald, James (July 18, 2019). 'How Does the Body Make Vitamin D from Sunlight?'. JSTOR Daily. Retrieved July 22, 2019.
4. ^Holick MF, MacLaughlin JA, Clark MB, Holick SA, Potts JT, Anderson RR, et al. (October 10, 1980). 'Photosynthesis of previtamin D3 in human skin and the physiologic consequences'. Science. 210 (4466): 203–5. doi:10.1126/science.6251551. ISSN0036-8075. JSTOR1685024. PMID6251551.
5. ^Calvo MS, Whiting SJ, Barton CN (February 2005). 'Vitamin D intake: a global perspective of current status'. The Journal of Nutrition. 135 (2): 310–6. doi:10.1093/jn/135.2.310. PMID15671233.
6. ^ ^abcdefNorman AW (August 2008). 'From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health'. The American Journal of Clinical Nutrition. 88 (2): 491S–499S. doi:10.1093/ajcn/88.2.491S. PMID18689389.
7. ^ ^abcde'Vitamin D Fact Sheet for Health Professionals'. National Institutes of Health (NIH). February 11, 2016. Retrieved June 6, 2017.This article incorporates text from this source, which is in the public domain.
8. ^Dierkes, Jutta; Stangl, Gabriele I.; Pot, Gerda K.; Erkkilä, Arja T.; Hansen, Anita Lill; Lindqvist, Helen; Lauritzen, Lotte; Mellgren, Gunnar; Ueland, Per Magne; Gudbrandsen, Oddrun Anita; Mueller-Belecke, Andreas; Hirche, Frank; Gjessing, Hanne Rosendahl; Lehmann, Ulrike (October 1, 2015). 'Efficacy of fish intake on vitamin D status: a meta-analysis of randomized controlled trials'. The American Journal of Clinical Nutrition. 102 (4): 837–847. doi:10.3945/ajcn.114.105395. PMID26354531.
9. ^'Vitamin D Tests'. Lab Tests Online (USA). American Association for Clinical Chemistry. Retrieved June 23, 2013.
10. ^Hollis BW (January 1996). 'Assessment of vitamin D nutritional and hormonal status: what to measure and how to do it'. Calcified Tissue International. 58 (1): 4–5. doi:10.1007/BF02509538. PMID8825231.
11. ^ ^abHolick MF, Schnoes HK, DeLuca HF, Suda T, Cousins RJ (July 1971). 'Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine'. Biochemistry. 10 (14): 2799–804. doi:10.1021/bi00790a023. PMID4326883.
12. ^ ^abcdWolf G (June 2004). 'The discovery of vitamin D: the contribution of Adolf Windaus'. The Journal of Nutrition. 134 (6): 1299–302. doi:10.1093/jn/134.6.1299. PMID15173387.
13. ^Pittas AG, Chung M, Trikalinos T, Mitri J, Brendel M, Patel K, et al. (March 2010). 'Systematic review: Vitamin D and cardiometabolic outcomes'. Annals of Internal Medicine. 152 (5): 307–14. doi:10.7326/0003-4819-152-5-201003020-00009. PMC3211092. PMID20194237.
14. ^ ^abChung M, Balk EM, Brendel M, Ip S, Lau J, Lee J, et al. (August 2009). 'Vitamin D and calcium: a systematic review of health outcomes'. Evidence Report/Technology Assessment (183): 1–420. PMC4781105. PMID20629479.
15. ^ ^abcdeBjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, et al. (January 2014). 'Vitamin D supplementation for prevention of mortality in adults'. The Cochrane Database of Systematic Reviews (Systematic review). 1 (1): CD007470. doi:10.1002/14651858.CD007470.pub3. PMID24414552.
16. ^ ^abcdefgBolland MJ, Grey A, Gamble GD, Reid IR (April 2014). 'The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis'. The Lancet Diabetes & Endocrinology (Meta-analysis). 2 (4): 307–20. doi:10.1016/S2213-8587(13)70212-2. PMID24703049.
17. ^Dorland's Illustrated Medical Dictionary, under Vitamin (Table of Vitamins)
18. ^ ^abcd'About Vitamin D'. University of California, Riverside. November 2011. Retrieved January 24, 2015.
19. ^Boron WF, Boulpaep EL (March 29, 2016). Medical Physiology E-Book. Elsevier Health Sciences. ISBN978-1-4557-3328-6.
20. ^Bouillon R, Van Cromphaut S, Carmeliet G (February 2003). 'Intestinal calcium absorption: Molecular vitamin D mediated mechanisms'. Journal of Cellular Biochemistry. 88 (2): 332–9. doi:10.1002/jcb.10360. PMID12520535.
21. ^ ^abBell TD, Demay MB, Burnett-Bowie SA (September 2010). 'The biology and pathology of vitamin D control in bone'. Journal of Cellular Biochemistry. 111 (1): 7–13. doi:10.1002/jcb.22661. PMC4020510. PMID20506379.
22. ^Watkins RR, Lemonovich TL, Salata RA (May 2015). 'An update on the association of vitamin D deficiency with common infectious diseases'. Canadian Journal of Physiology and Pharmacology. 93 (5): 363–8. doi:10.1139/cjpp-2014-0352. PMID25741906.
23. ^Puchacz E, Stumpf WE, Stachowiak EK, Stachowiak MK (February 1996). 'Vitamin D increases expression of the tyrosine hydroxylase gene in adrenal medullary cells'. Brain Research. Molecular Brain Research. 36 (1): 193–6. doi:10.1016/0169-328X(95)00314-I. PMID9011759.
24. ^'Rickets'. National Health Service. March 8, 2012. Retrieved July 9, 2012.
25. ^Munns, CF; Shaw, N; Kiely, M; Specker, BL; Thacher, TD; Ozono, K; et al. (February 2016). 'Global Consensus Recommendations on Prevention and Management of Nutritional Rickets'. The Journal of clinical endocrinology and metabolism. 101 (2): 394–415. doi:10.1210/jc.2015-2175. PMID26745253.
26. ^Eriksen EF, Glerup H (2002). 'Vitamin D deficiency and aging: implications for general health and osteoporosis'. Biogerontology. 3 (1–2): 73–7. doi:10.1023/A:1015263514765. PMID12014847.
27. ^ ^abcdefHolick MF (July 2007). 'Vitamin D deficiency'. The New England Journal of Medicine. 357 (3): 266–81. doi:10.1056/NEJMra070553. PMID17634462.
28. ^ ^abcdBrown JE, Isaacs J, Krinke B, Lechtenberg E, Murtaugh M (June 28, 2013). Nutrition Through the Life Cycle. Cengage Learning. ISBN978-1-285-82025-5.
29. ^Schoenmakers I, Goldberg GR, Prentice A (June 2008). 'Abundant sunshine and vitamin D deficiency'. The British Journal of Nutrition. 99 (6): 1171–3. doi:10.1017/S0007114508898662. PMC2758994. PMID18234141.
30. ^Lerch C, Meissner T (October 2007). Lerch C (ed.). 'Interventions for the prevention of nutritional rickets in term born children'. The Cochrane Database of Systematic Reviews (4): CD006164. doi:10.1002/14651858.CD006164.pub2. PMID17943890.
31. ^Zargar AH, Mithal A, Wani AI, Laway BA, Masoodi SR, Bashir MI, et al. (June 2000). 'Pseudovitamin D deficiency rickets--a report from the Indian subcontinent'. Postgraduate Medical Journal. 76 (896): 369–72. doi:10.1136/pmj.76.896.369. PMC1741602. PMID10824056.
32. ^Elidrissy AT (September 2016). 'The Return of Congenital Rickets, Are We Missing Occult Cases?'. Calcified Tissue International (Review). 99 (3): 227–36. doi:10.1007/s00223-016-0146-2. PMID27245342.
33. ^Paterson CR, Ayoub D (October 2015). 'Congenital rickets due to vitamin D deficiency in the mothers'. Clinical Nutrition (Review). 34 (5): 793–8. doi:10.1016/j.clnu.2014.12.006. PMID25552383.
34. ^Oramasionwu GE, Thacher TD, Pam SD, Pettifor JM, Abrams SA (August 2008). 'Adaptation of calcium absorption during treatment of nutritional rickets in Nigerian children'(PDF). The British Journal of Nutrition. 100 (2): 387–92. doi:10.1017/S0007114507901233. PMID18197991.
35. ^Fischer PR, Rahman A, Cimma JP, Kyaw-Myint TO, Kabir AR, Talukder K, et al. (October 1999). 'Nutritional rickets without vitamin D deficiency in Bangladesh'. Journal of Tropical Pediatrics. 45 (5): 291–3. doi:10.1093/tropej/45.5.291. PMID10584471.
36. ^ ^abDunnigan MG, Henderson JB (November 1997). 'An epidemiological model of privational rickets and osteomalacia'. The Proceedings of the Nutrition Society. 56 (3): 939–56. doi:10.1079/PNS19970100. PMID9483661.
37. ^Robertson I, Ford JA, McIntosh WB, Dunnigan MG (January 1981). 'The role of cereals in the aetiology of nutritional rickets: the lesson of the Irish National Nutrition Survey 1943-8'. The British Journal of Nutrition. 45 (1): 17–22. doi:10.1079/BJN19810073. PMID6970590.CS1 maint: display-authors (link)
38. ^Clements MR (1989). 'The problem of rickets in UK Asians'. Journal of Human Nutrition and Dietetics. 2 (2): 105–116. doi:10.1111/j.1365-277X.1989.tb00015.x.
39. ^ ^abPettifor JM (December 2004). 'Nutritional rickets: deficiency of vitamin D, calcium, or both?'. The American Journal of Clinical Nutrition. 80 (6 Suppl): 1725S–9S. doi:10.1093/ajcn/80.6.1725S. PMID15585795.
40. ^ ^abDunnigan MG, Henderson JB, Hole DJ, Barbara Mawer E, Berry JL (December 2005). 'Meat consumption reduces the risk of nutritional rickets and osteomalacia'. The British Journal of Nutrition. 94 (6): 983–91. doi:10.1079/BJN20051558. PMID16351777.
41. ^'Cell Biology and Cancer Curriculum Supplement'. Office of Science Education. Archived from the original on June 8, 2010. Retrieved August 24, 2010.This article incorporates text from this source, which is in the public domain.
42. ^Weick MT (November 1967). 'A history of rickets in the United States'. The American Journal of Clinical Nutrition. 20 (11): 1234–41. doi:10.1093/ajcn/20.11.1234. PMID4862158.
43. ^Garrison RH, Somer E (1997). The Nutrition Desk Reference. McGraw-Hill. ISBN978-0-87983-826-3.
44. ^Dupuis EM (February 1, 2002). Nature's Perfect Food: How Milk Became America's Drink. NYU Press. ISBN978-0-8147-1938-1.
45. ^Teegarden D, Lyle RM, Proulx WR, Johnston CC, Weaver CM (May 1999). 'Previous milk consumption is associated with greater bone density in young women'. The American Journal of Clinical Nutrition. 69 (5): 1014–7. doi:10.1093/ajcn/69.5.1014. PMID10232644.
46. ^ ^abcInsel P, Ross D, Bernstein M, McMahon K (March 18, 2015). Discovering Nutrition. Jones & Bartlett Publishers. ISBN978-1-284-06465-0.
47. ^Holick MF (2003). 'Vitamin D: A millenium perspective'. Journal of Cellular Biochemistry. 88 (2): 296–307. doi:10.1002/jcb.10338. PMID12520530.
48. ^Straube S, Andrew Moore R, Derry S, McQuay HJ (2009). 'Vitamin D and chronic pain'. Pain. 141 (1–2): 10–13. doi:10.1016/j.pain.2008.11.010. PMID19084336.
49. ^Gaikwad M, Vanlint S, Mittinity M, Moseley GL, Stocks N (2016). 'Does vitamin D supplementation alleviate chronic nonspecific musculoskeletal pain? A systematic review and meta-analysis'. Clinical Rheumatology. 36 (5): 1201–1208. doi:10.1007/s10067-016-3205-1. PMID26861032.CS1 maint: display-authors (link)
50. ^Lowe NM, Bhojani I (2017). 'Special considerations for vitamin D in the south Asian population in the UK'. Therapeutic Advances in Musculoskeletal Disease. 9 (6): 137–144. doi:10.1177/1759720X17704430. PMC5466148. PMID28620422.
51. ^O'Connor MY, Thoreson CK, Ramsey NL, Ricks M, Sumner AE (2013). 'The uncertain significance of low vitamin D levels in African descent populations: a review of the bone and cardiometabolic literature'. Progress in Cardiovascular Diseases. 56 (3): 261–269. doi:10.1016/j.pcad.2013.10.015. PMC3894250. PMID24267433.
52. ^ ^abFreedman BI, Register TC (2012). 'Effect of race and genetics on vitamin D metabolism, bone and vascular health'. Nature Reviews Nephrology. 8 (8): 459–466. doi:10.1038/nrneph.2012.112. PMID22688752.
53. ^Khalid AT, Moore CG, Hall C, Olabopo F, Rozario NL, Holick MF, et al. (2017). 'Utility of sun-reactive skin typing and melanin index for discerning vitamin D deficiency'. Pediatric Research. 82 (3): 444–451. doi:10.1038/pr.2017.114. PMC5570640. PMID28467404.
54. ^Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis JP (April 2014). 'Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials'. BMJ. 348: g2035. doi:10.1136/bmj.g2035. PMC3972415. PMID24690624.
55. ^ ^abcAutier P, Boniol M, Pizot C, Mullie P (January 2014). 'Vitamin D status and ill health: a systematic review'. The Lancet Diabetes & Endocrinology. 2 (1): 76–89. doi:10.1016/S2213-8587(13)70165-7. PMID24622671.
56. ^Hussain S, Singh A, Akhtar M, Najmi AK (September 2017). 'Vitamin D supplementation for the management of knee osteoarthritis: a systematic review of randomized controlled trials'. Rheumatology International. 37 (9): 1489–1498. doi:10.1007/s00296-017-3719-0. PMID28421358.
57. ^ ^{abcdefghijklm}Institute of Medicine (IoM) (2011). '8, Implications and Special Concerns'. In Ross AC, Taylor CL, Yaktine AL, Del Valle HB (eds.). Dietary Reference Intakes for Calcium and Vitamin D. The National Academies Collection: Reports funded by National Institutes of Health. National Academies Press. doi:10.17226/13050. ISBN978-0-309-16394-1. PMID21796828.
58. ^ ^abMaxmen A (July 2011). 'Nutrition advice: the vitamin D-lemma'. Nature. 475 (7354): 23–5. doi:10.1038/475023a. PMID21734684.
59. ^Schöttker B, Jorde R, Peasey A, Thorand B, Jansen EH, Groot LD, et al. (June 2014). 'Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States'. BMJ. 348 (jun17 16): g3656. doi:10.1136/bmj.g3656. PMC4061380. PMID24938302.
60. ^Tuohimaa P (March 2009). 'Vitamin D and aging'. The Journal of Steroid Biochemistry and Molecular Biology. 114 (1–2): 78–84. doi:10.1016/j.jsbmb.2008.12.020. PMID19444937.
61. ^Tuohimaa P, Keisala T, Minasyan A, Cachat J, Kalueff A (December 2009). 'Vitamin D, nervous system and aging'. Psychoneuroendocrinology. 34 Suppl 1: S278–86. doi:10.1016/j.psyneuen.2009.07.003. PMID19660871.
62. ^Manya H, Akasaka-Manya K, Endo T (July 2010). 'Klotho protein deficiency and aging'. Geriatrics & Gerontology International. 10 Suppl 1 (Suppl 1): S80–7. doi:10.1111/j.1447-0594.2010.00596.x. PMID20590845.
63. ^Reid IR, Bolland MJ, Grey A (January 2014). 'Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis'. Lancet. 383 (9912): 146–55. doi:10.1016/s0140-6736(13)61647-5. PMID24119980.
64. ^Avenell A, Mak JC, O'Connell D (April 2014). 'Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men'. The Cochrane Database of Systematic Reviews. 4 (4): CD000227. doi:10.1002/14651858.CD000227.pub4. PMID24729336.CS1 maint: display-authors (link)
65. ^Bischoff-Ferrari HA, Willett WC, Orav EJ, Oray EJ, Lips P, Meunier PJ, et al. (July 2012). 'A pooled analysis of vitamin D dose requirements for fracture prevention'(PDF). The New England Journal of Medicine. 367 (1): 40–9. doi:10.1056/NEJMoa1109617. hdl:1871/48765. PMID22762317.
66. ^ ^abChung M, Lee J, Terasawa T, Lau J, Trikalinos TA (December 2011). 'Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force'. Annals of Internal Medicine. 155 (12): 827–38. doi:10.7326/0003-4819-155-12-201112200-00005. PMID22184690.
67. ^Zhao JG, Zeng XT, Wang J, Liu L (December 2017). 'Association Between Calcium or Vitamin D Supplementation and Fracture Incidence in Community-Dwelling Older Adults: A Systematic Review and Meta-analysis'. JAMA. 318 (24): 2466–2482. doi:10.1001/jama.2017.19344. PMC5820727. PMID29279934.CS1 maint: display-authors (link)
68. ^Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, et al. (August 2007). 'Effectiveness and safety of vitamin D in relation to bone health'. Evidence Report/Technology Assessment (158): 1–235. PMC4781354. PMID18088161.
69. ^Bolland MJ, Grey A, Gamble GD, Reid IR (July 2014). 'Vitamin D supplementation and falls: a trial sequential meta-analysis'. The Lancet Diabetes & Endocrinology. 2 (7): 573–80. doi:10.1016/S2213-8587(14)70068-3. PMID24768505.
70. ^Shuler FD, Wingate MK, Moore GH, Giangarra C (November 2012). 'Sports health benefits of vitamin d'. Sports Health. 4 (6): 496–501. doi:10.1177/1941738112461621. PMC3497950. PMID24179588.
71. ^ ^abc'Changes to the Nutrition Facts Label'. Food and Drug Administration (FDA). June 18, 2019. Retrieved July 16, 2019.This article incorporates text from this source, which is in the public domain.
72. ^Byers T (July 2010). 'Anticancer vitamins du Jour--The ABCED's so far'. American Journal of Epidemiology (Review). 172 (1): 1–3. doi:10.1093/aje/kwq112. PMC2892535. PMID20562190.
73. ^Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ (May 2014). 'The role of vitamin D in reducing cancer risk and progression'. Nature Reviews. Cancer. 14 (5): 342–57. doi:10.1038/nrc3691. PMID24705652.
74. ^Buttigliero C, Monagheddu C, Petroni P, Saini A, Dogliotti L, Ciccone G, et al. (2011). 'Prognostic role of vitamin d status and efficacy of vitamin D supplementation in cancer patients: a systematic review'. The Oncologist. 16 (9): 1215–27. doi:10.1634/theoncologist.2011-0098. PMC3228169. PMID21835895.
75. ^Li M, Chen P, Li J, Chu R, Xie D, Wang H (July 2014). 'Review: the impacts of circulating 25-hydroxyvitamin D levels on cancer patient outcomes: a systematic review and meta-analysis'. The Journal of Clinical Endocrinology and Metabolism. 99 (7): 2327–36. doi:10.1210/jc.2013-4320. PMID24780061.
76. ^Barbarawi M, Kheiri B, Zayed Y, Barbarawi O, Dhillon H, Swaid B, et al. (June 19, 2019). 'Vitamin D Supplementation and Cardiovascular Disease Risks in More Than 83 000 Individuals in 21 Randomized Clinical Trials: A Meta-analysis'. JAMA Cardiology. doi:10.1001/jamacardio.2019.1870. ISSN2380-6583. PMC6584896. PMID31215980.
77. ^Beveridge LA, Struthers AD, Khan F, Jorde R, Scragg R, Macdonald HM, et al. (May 2015). 'Effect of Vitamin D Supplementation on Blood Pressure: A Systematic Review and Meta-analysis Incorporating Individual Patient Data'. JAMA Internal Medicine. 175 (5): 745–54. doi:10.1001/jamainternmed.2015.0237. PMC5966296. PMID25775274.
78. ^Hewison M (2011). 'Vitamin D and innate and adaptive immunity'. Vitamins and the Immune System. Vitamins & Hormones. 86. pp. 23–62. doi:10.1016/B978-0-12-386960-9.00002-2. ISBN9780123869609. PMID21419266.
79. ^Beard JA, Bearden A, Striker R (2011). 'Vitamin D and the anti-viral state'. Journal of Clinical Virology. 50 (3): 194–200. doi:10.1016/j.jcv.2010.12.006. PMC3308600. PMID21242105.
80. ^Spector SA (2011). 'Vitamin D and HIV: letting the sun shine in'. Topics in Antiviral Medicine. 19 (1): 6–10. PMC6148856. PMID21852710.
81. ^Nnoaham KE, Clarke A (2008). 'Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis'. International Journal of Epidemiology. 37 (1): 113–119. CiteSeerX10.1.1.513.3969. doi:10.1093/ije/dym247. PMID18245055.
82. ^Luong KV, Nguyen LT (2011). 'Impact of vitamin D in the treatment of tuberculosis'. The American Journal of the Medical Sciences. 341 (6): 493–498. doi:10.1097/MAJ.0b013e3182070f47. PMID21289501.
83. ^Bergman P, Lindh AU, Björkhem-Bergman L, Lindh JD (2013). 'Vitamin D and Respiratory Tract Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials'. PLOS ONE. 8 (6): e65835. Bibcode:2013PLoSO...865835B. doi:10.1371/journal.pone.0065835. PMC3686844. PMID23840373.
84. ^Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, et al. (2017). 'Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data'. BMJ. 356: i6583. doi:10.1136/bmj.i6583. PMC5310969. PMID28202713.
85. ^Autier P, Mullie P, Macacu A, Dragomir M, Boniol M, Coppens K, et al. (2017). 'Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of meta-analyses and randomised trials'. The Lancet. Diabetes & Endocrinology. 5 (12): 986–1004. doi:10.1016/S2213-8587(17)30357-1. PMID29102433.
86. ^Yakoob MY, Salam RA, Khan FR, Bhutta ZA (2016). 'Vitamin D supplementation for preventing infections in children under five years of age'. The Cochrane Database of Systematic Reviews. 11: CD008824. doi:10.1002/14651858.cd008824.pub2. PMC5450876. PMID27826955.
87. ^Hart PH (June 2012). 'Vitamin D supplementation, moderate sun exposure, and control of immune diseases'. Discovery Medicine. 13 (73): 397–404. PMID22742645.
88. ^Paul G, Brehm JM, Alcorn JF, Holguín F, Aujla SJ, Celedón JC (2012). 'Vitamin D and asthma'. American Journal of Respiratory and Critical Care Medicine. 185 (2): 124–132. doi:10.1164/rccm.201108-1502CI. PMC3297088. PMID22016447.
89. ^Pakpoor J, Ramagopalan S (2014). 'Evidence for an Association Between Vitamin D and Multiple Sclerosis'. Emerging and Evolving Topics in Multiple Sclerosis Pathogenesis and Treatments. Current Topics in Behavioral Neurosciences. 26. pp. 105–115. doi:10.1007/7854_2014_358. ISBN978-3-319-25541-5. PMID25502544. The evidence for vitamin D as a treatment for MS is inconclusive.
90. ^Pozuelo-Moyano B, Benito-León J, Mitchell AJ, Hernández-Gallego J (2013). 'A systematic review of randomized, double-blind, placebo-controlled trials examining the clinical efficacy of vitamin D in multiple sclerosis'. Neuroepidemiology (Systematic Review). 40 (3): 147–153. doi:10.1159/000345122. PMC3649517. PMID23257784. The available evidence substantiates neither clinically significant benefit nor harm from vitamin D in the treatment of patients with MS.
91. ^Thomas JS, Ellen MM (2018). 'A review of vitamin D supplementation as disease-modifying therapy'. Multiple Sclerosis Journal (Systematic Review). 24 (1): 6–11. doi:10.1177/1352458517738131. PMID29307295. Several preliminary studies have reported results which have shown some promise, but none has yet provided significant evidence of a clinically meaningful improvement.
92. ^ ^abDel Pinto R, Pietropaoli D, Chandar AK, Ferri C, Cominelli F (November 2015). 'Association Between Inflammatory Bowel Disease and Vitamin D Deficiency: A Systematic Review and Meta-analysis'. Inflammatory Bowel Diseases. 21 (11): 2708–2717. doi:10.1097/MIB.0000000000000546. PMC4615394. PMID26348447.
93. ^Del Pinto R, Ferri C, Cominelli F (November 2017). 'Vitamin D Axis in Inflammatory Bowel Diseases: Role, Current Uses and Future Perspectives'. International Journal of Molecular Sciences. 18 (11): 2360. doi:10.3390/ijms18112360. PMC5713329. PMID29112157.
94. ^Seida JC, Mitri J, Colmers IN, Majumdar SR, Davidson MB, Edwards AL, et al. (October 2014). 'Clinical review: Effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysis'. The Journal of Clinical Endocrinology and Metabolism (Review). 99 (10): 3551–60. doi:10.1210/jc.2014-2136. PMC4483466. PMID25062463.
95. ^Nakashima A, Yokoyama K, Yokoo T, Urashima M (March 2016). 'Role of vitamin D in diabetes mellitus and chronic kidney disease'. World Journal of Diabetes (Review). 7 (5): 89–100. doi:10.4239/wjd.v7.i5.89. PMC4781904. PMID26981182.
96. ^Shaffer JA, Edmondson D, Wasson LT, Falzon L, Homma K, Ezeokoli N, et al. (April 2014). 'Vitamin D supplementation for depressive symptoms: a systematic review and meta-analysis of randomized controlled trials'. Psychosomatic Medicine. 76 (3): 190–6. doi:10.1097/psy.0000000000000044. PMC4008710. PMID24632894.
97. ^Balion C, Griffith LE, Strifler L, Henderson M, Patterson C, Heckman G, et al. (September 2012). 'Vitamin D, cognition, and dementia: a systematic review and meta-analysis'. Neurology. 79 (13): 1397–405. doi:10.1212/WNL.0b013e31826c197f. PMC3448747. PMID23008220.
98. ^ ^abAghajafari F, Nagulesapillai T, Ronksley PE, Tough SC, O'Beirne M, Rabi DM (March 2013). 'Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies'. BMJ. 346: f1169. doi:10.1136/bmj.f1169. PMID23533188.
99. ^ ^abcPalacios C, De-Regil LM, Lombardo LK, Peña-Rosas JP (November 2016). 'Vitamin D supplementation during pregnancy: Updated meta-analysis on maternal outcomes'. The Journal of Steroid Biochemistry and Molecular Biology. 164: 148–155. doi:10.1016/j.jsbmb.2016.02.008. PMC5357731. PMID26877200.
100. ^Roth DE, Leung M, Mesfin E, Qamar H, Watterworth J, Papp E (November 2017). 'Vitamin D supplementation during pregnancy: state of the evidence from a systematic review of randomised trials'. BMJ. 359: j5237. doi:10.1136/bmj.j5237. PMC5706533. PMID29187358.
101. ^ ^abWagner CL, Taylor SN, Dawodu A, Johnson DD, Hollis BW (March 2012). 'Vitamin D and its role during pregnancy in attaining optimal health of mother and fetus'. Nutrients. 4 (3): 208–30. doi:10.3390/nu4030208. PMC3347028. PMID22666547.
102. ^Bi WG, Nuyt AM, Weiler H, Leduc L, Santamaria C, Wei SQ (May 2018). 'Association Between Vitamin D Supplementation During Pregnancy and Offspring Growth, Morbidity, and Mortality: A Systematic Review and Meta-analysis'. JAMA Pediatrics. 172 (7): 635–645. doi:10.1001/jamapediatrics.2018.0302. PMC6137512. PMID29813153.
103. ^Pathak K, Soares MJ, Calton EK, Zhao Y, Hallett J (June 2014). 'Vitamin D supplementation and body weight status: a systematic review and meta-analysis of randomized controlled trials'. Obesity Reviews. 15 (6): 528–37. doi:10.1111/obr.12162. PMID24528624.
104. ^Mallard SR, Howe AS, Houghton LA (October 2016). 'Vitamin D status and weight loss: a systematic review and meta-analysis of randomized and nonrandomized controlled weight-loss trials'. The American Journal of Clinical Nutrition. 104 (4): 1151–1159. doi:10.3945/ajcn.116.136879. PMID27604772.
105. ^ ^abcEuropean Food Safety Authority (EFSA) Panel on Dietetic Products, Nutrition and Allergies (NDA) (2010). 'Scientific opinion on the substantiation of health claims related to vitamin D and normal function of the immune system and inflammatory response (ID 154, 159), maintenance of normal muscle function (ID 155) and maintenance of normal cardiovascular function (ID 159) pursuant to Article 13(1) of Regulation (EC) No 1924/2006'. EFSA Journal. 8 (2): 1468–85. doi:10.2903/j.efsa.2010.1468.
106. ^European Food Safety Authority (EFSA) Panel on Dietetic Products, Nutrition and Allergies (NDA) (2011). 'Scientific opinion on the substantiation of a health claim related to vitamin D and risk of falling pursuant to Article 14 of Regulation (EC) No 1924/2006'(PDF). EFSA Journal. 9 (9): 2382–2400. doi:10.2903/j.efsa.2011.2382.
107. ^'Guidance for Industry: Food Labeling Guide'. Food and Drug Administration (FDA). January 2013.This article incorporates text from this source, which is in the public domain.
108. ^'Health Canada Scientific Summary on the U. S. Health Claim Regarding Calcium and Osteoporosis'. Bureau of Nutritional Sciences Food Directorate, Health Products and Food Branch Health Canada. May 1, 2000.
109. ^'Regulatory Systems of Health Claims in Japan'(PDF). Japan Consumer Affairs Agency, Food Labelling Division. June 1, 2011. Archived from the original(PDF) on March 6, 2012. Retrieved January 29, 2012.
110. ^'Vitamin D'. Nutrient Reference Values for Australia and New Zealand. Australian Ministry of Health. September 9, 2005. Archived from the original on February 27, 2012.
111. ^ ^abc'Vitamin D and Calcium: Updated Dietary Reference Intakes'. Nutrition and Healthy Eating. Health Canada. December 5, 2008. Retrieved April 28, 2018.
112. ^ ^abc'Nutrient reference values for Australia and New Zealand'(PDF). National Health and Medical Research Council. September 9, 2005. Archived from the original(PDF) on January 21, 2017. Retrieved April 28, 2018.
113. ^ ^abcdEFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (June 29, 2016). 'Dietary reference values for vitamin D'. EFSA Journal. 14 (10): e04547. doi:10.2903/j.efsa.2016.4547.
114. ^ ^abEFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (2012). 'Scientific Opinion on the Tolerable Upper Intake Level of vitamin D'. EFSA Journal (Submitted manuscript). 10 (7). doi:10.2903/j.efsa.2012.2813.
115. ^'Federal Register May 27, 2016 Food Labeling: Revision of the Nutrition and Supplement Facts Labels. FR page 33982'(PDF). Retrieved August 20, 2019.This article incorporates text from this source, which is in the public domain.
116. ^Salleh A (June 12, 2012). 'Vitamin D food fortification on the table'. Australian Broadcasting Corporation.CS1 maint: Uses authors parameter (link)
117. ^'Vitamins and minerals – Vitamin D'. National Health Service. February 18, 2015. Retrieved July 21, 2016.
118. ^'PHE publishes new advice on vitamin D'. Public Health England. July 21, 2016. Retrieved July 21, 2016.
119. ^'Vitamin D (translated)' (in Swedish). Swedish National Food Agency. Retrieved October 19, 2018.
120. ^Vitamin-D-Bedarf bei fehlender endogener Synthese Deutsche Gesellschaft für Ernährung, January 2012
121. ^Pérez-López FR, Brincat M, Erel CT, Tremollieres F, Gambacciani M, Lambrinoudaki I, et al. (January 2012). 'EMAS position statement: Vitamin D and postmenopausal health'. Maturitas. 71 (1): 83–8. doi:10.1016/j.maturitas.2011.11.002. PMID22100145.
122. ^Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes (1997). DRI, Dietary reference intakes: for calcium, phosphorus, magnesium, vitamin D, and fluoride. Washington, D.C: National Academy Press. p. 250. doi:10.17226/5776. ISBN978-0-309-06350-0. PMID23115811.
123. ^ ^abcHolick MF (1992). 'Evolutionary biology and pathology of vitamin D'. J. Nutr. Sci. Vitaminol. Spec No: 79–83. doi:10.3177/jnsv.38.Special_79. PMID1297827.
124. ^ ^abcdefKeegan RJ, Lu Z, Bogusz JM, Williams JE, Holick MF (January 2013). 'Photobiology of vitamin D in mushrooms and its bioavailability in humans'. Dermato-Endocrinology. 5 (1): 165–76. doi:10.4161/derm.23321. PMC3897585. PMID24494050.
125. ^ ^abWang T, Bengtsson G, Kärnefelt I, Björn LO (September 2001). 'Provitamins and vitamins D₂ and D₃ in Cladina spp. over a latitudinal gradient: possible correlation with UV levels'. Journal of Photochemistry and Photobiology. B, Biology (Submitted manuscript). 62 (1–2): 118–22. doi:10.1016/S1011-1344(01)00160-9. PMID11693362.
126. ^Haytowitz DB (2009). 'Vitamin D in mushrooms'(PDF). Nutrient Data Laboratory, US Department of Agriculture. Retrieved April 16, 2018.This article incorporates text from this source, which is in the public domain.
127. ^'Search, National Nutrient Database for Standard Reference Release 27'. US Department of Agriculture, Agricultural Research Service. 2014. Retrieved June 12, 2015.This article incorporates text from this source, which is in the public domain.
128. ^de Lourdes Samaniego-Vaesken M, Alonso-Aperte E, Varela-Moreiras G (2012). 'Vitamin food fortification today'. Food & Nutrition Research. 56: 5459. doi:10.3402/fnr.v56i0.5459. PMC3319130. PMID22481896.
129. ^ ^abSpiro A, Buttriss JL (December 2014). 'Vitamin D: An overview of vitamin D status and intake in Europe'. Nutrition Bulletin. 39 (4): 322–350. doi:10.1111/nbu.12108. PMC4288313. PMID25635171.
130. ^'Vitamin D for Milk and Milk Alternatives'. Food and Drug Administration (FDA). July 15, 2016. Retrieved February 22, 2017.This article incorporates text from this source, which is in the public domain.
131. ^'Federal Register: Food Additives Permitted for Direct Addition to Food for Human Consumption; Vitamin D2'. Food and Drug Administration, US Department of Health and Human Services. July 18, 2016. Retrieved February 22, 2017.This article incorporates text from this source, which is in the public domain.
132. ^'§172.379 Vitamin D2'. Electronic Code of Federal Regulations. Retrieved July 16, 2019.This article incorporates text from this source, which is in the public domain.
133. ^'§172.380 Vitamin D3'. Electronic Code of Federal Regulations. Retrieved July 16, 2019.This article incorporates text from this source, which is in the public domain.
134. ^Tripkovic L (2013). 'Vitamin D₂ vs. vitamin D₃: Are they one and the same?'. Nutrition Bulletin. 38 (2): 243–248. doi:10.1111/nbu.12029.
135. ^Alshahrani F, Aljohani N (September 2013). 'Vitamin D: deficiency, sufficiency and toxicity'. Nutrients. 5 (9): 3605–16. doi:10.3390/nu5093605. PMC3798924. PMID24067388.
136. ^Biancuzzo RM, Clarke N, Reitz RE, Travison TG, Holick MF (March 2013). 'Serum concentrations of 1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 in response to vitamin D2 and vitamin D3 supplementation'. The Journal of Clinical Endocrinology and Metabolism. 98 (3): 973–9. doi:10.1210/jc.2012-2114. PMC3590486. PMID23386645.
137. ^Borel P, Caillaud D, Cano NJ (2015). 'Vitamin D bioavailability: state of the art'. Critical Reviews in Food Science and Nutrition. 55 (9): 1193–205. doi:10.1080/10408398.2012.688897. PMID24915331.
138. ^Jakobsen J, Knuthsen P (April 2014). 'Stability of vitamin D in foodstuffs during cooking'. Food Chemistry. 148: 170–5. doi:10.1016/j.foodchem.2013.10.043. PMID24262542.
139. ^Wahl DA, Cooper C, Ebeling PR, Eggersdorfer M, Hilger J, Hoffmann K, et al. (August 29, 2012). 'A global representation of vitamin D status in healthy populations'(PDF). Archives of Osteoporosis. 7 (1–2): 155–72. doi:10.1007/s11657-012-0093-0. hdl:11343/220606. PMID23225293.
140. ^Wahl DA, Cooper C, Ebeling PR, Eggersdorfer M, Hilger J, Hoffmann K, et al. (February 1, 2013). 'A global representation of vitamin D status in healthy populations: reply to comment by Saadi'. Archives of Osteoporosis. 8 (1–2): 122. doi:10.1007/s11657-013-0122-7. PMID23371520.
141. ^Bischoff-Ferrari HA (2014). Optimal serum 25-hydroxyvitamin D levels for multiple health outcomes. Advances in Experimental Medicine and Biology (Review). 810. pp. 500–25. doi:10.1007/978-0-387-77574-6_5. ISBN978-0-387-77573-9. PMID25207384.
142. ^ ^abDahlquist DT, Dieter BP, Koehle MS (2015). 'Plausible ergogenic effects of vitamin D on athletic performance and recovery'. Journal of the International Society of Sports Nutrition (Review). 12: 33. doi:10.1186/s12970-015-0093-8. PMC4539891. PMID26288575.
143. ^Engelman CD, Fingerlin TE, Langefeld CD, Hicks PJ, Rich SS, Wagenknecht LE, et al. (September 2008). 'Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans'. The Journal of Clinical Endocrinology and Metabolism. 93 (9): 3381–8. doi:10.1210/jc.2007-2702. PMC2567851. PMID18593774.
144. ^Wang L, Song Y, Manson JE, Pilz S, März W, Michaëlsson K, et al. (2012). 'Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies'. Circulation: Cardiovascular Quality and Outcomes. 5 (6): 819–29. doi:10.1161/CIRCOUTCOMES.112.967604. PMC3510675. PMID23149428.
145. ^ ^abRoss AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. (January 2011). 'The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know'. The Journal of Clinical Endocrinology and Metabolism. 96 (1): 53–8. doi:10.1210/jc.2010-2704. PMC3046611. PMID21118827.
146. ^ ^abcVitamin D at Merck Manual of Diagnosis and Therapy Professional Edition
147. ^ ^abcdVieth R (May 1999). 'Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety'(PDF). The American Journal of Clinical Nutrition. 69 (5): 842–56. doi:10.1093/ajcn/69.5.842. PMID10232622.
148. ^Tolerable Upper Intake Limits for Vitamins And Minerals(PDF). European Food Safety Authority. December 2006. ISBN978-92-9199-014-6.
149. ^'FDA Cautions on Accurate Vitamin D Supplementation for Infants' (Press release). Food and Drug Administration (FDA). June 15, 2010. Archived from the original on January 12, 2017.This article incorporates text from this source, which is in the public domain.
150. ^Olmos-Ortiz A, Avila E, Durand-Carbajal M, Díaz L (January 2015). 'Regulation of calcitriol biosynthesis and activity: focus on gestational vitamin D deficiency and adverse pregnancy outcomes'. Nutrients. 7 (1): 443–80. doi:10.3390/nu7010443. PMC4303849. PMID25584965.
151. ^Holick MF (April 1987). 'Photosynthesis of vitamin D in the skin: effect of environmental and life-style variables'. Federation Proceedings. 46 (5): 1876–82. PMID3030826.
152. ^Deluca HF (January 2014). 'History of the discovery of vitamin D and its active metabolites'. BoneKEy Reports. 3: 479. doi:10.1038/bonekey.2013.213. PMC3899558. PMID24466410.
153. ^ ^abHolick MF (March 2004). 'Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis'. The American Journal of Clinical Nutrition. 79 (3): 362–71. doi:10.1093/ajcn/79.3.362. PMID14985208.
154. ^Eyley SC, Williams DH (1975). 'Photolytic production of vitamin D. The preparative value of a photo-sensitiser'. Journal of the Chemical Society, Chemical Communications (20): 858a. doi:10.1039/C3975000858A.
155. ^Crissey SD, Ange KD, Jacobsen KL, Slifka KA, Bowen PE, Stacewicz-Sapuntzakis M, et al. (January 2003). 'Serum concentrations of lipids, vitamin d metabolites, retinol, retinyl esters, tocopherols and selected carotenoids in twelve captive wild felid species at four zoos'. The Journal of Nutrition. 133 (1): 160–6. doi:10.1093/jn/133.1.160. PMID12514284.
156. ^Holick MF (2018). 'Chapter 4: Photobiology of Vitamin D'. In Feldman D, Wesley Pike J, Bouillon R, Giovannucci E, Goltzman D, Hewison M (eds.). Vitamin D: Volume 1: Biochemistry, Physiology and Diagnostics (4th ed.). London, UK: Academic Press. ISBN978-0-12-809965-0.
157. ^Ray CC (May 17, 2005). 'Q&A Sunshine Vitamin D'. The New York Times. Archived from the original on February 21, 2013. Retrieved March 8, 2013.
158. ^Bolton J. 'UV FAQs'. International Ultraviolet Association. Archived from the original on May 30, 2013.
159. ^Holick MF (February 2002). 'Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health'. Current Opinion in Endocrinology, Diabetes and Obesity. 9 (1): 87–98. doi:10.1097/00060793-200202000-00011.
160. ^Holick MF (September 2002). 'Sunlight and vitamin D: both good for cardiovascular health'. Journal of General Internal Medicine. 17 (9): 733–5. doi:10.1046/j.1525-1497.2002.20731.x. PMC1495109. PMID12220371.
161. ^ ^abHolick MF, Smith E, Pincus S (December 1987). 'Skin as the site of vitamin D synthesis and target tissue for 1,25-dihydroxyvitamin D3. Use of calcitriol (1,25-dihydroxyvitamin D3) for treatment of psoriasis'. Archives of Dermatology. 123 (12): 1677–1683a. doi:10.1001/archderm.1987.01660360108022. PMID2825606.
162. ^'Anatomy of the skin'. National Cancer Institute, US National Institutes of Health, Bethesda. 2016. Retrieved December 19, 2016.
163. ^'Vitamin D and Skin Health'. LINUS PAULING INSTITUTE Micronutrient Information Center. Oregon State University. November 7, 2016. Retrieved March 30, 2017.
164. ^Holick MF (April 1, 2010). The Vitamin D Solution: A 3-Step Strategy to Cure Our Most Common Health Problems. Penguin Publishing Group. ISBN978-1-101-22293-5.
165. ^Agarwal SC, Stout SD (June 28, 2011). Bone Loss and Osteoporosis: An Anthropological Perspective. Springer Science & Business Media. ISBN978-1-4419-8891-1. Archived(PDF) from the original on January 29, 2006. The high 25(OH)D concentrations, and relatively high vitamin D requirements of apes and monkeys are understandable in light of their biology—their body surface area relative to mass is generally greater than for humans, and they are inveterate groomers, consuming by mouth the vitamin D generated from the oils secreted by skin into fur. Although much of the vitamin D produced within human skin is absorbed directly, birds and furbearing animals acquire most of their vitamin D orally, as they groom themselves (Bicknell and Prescott, 1946; Carpenter and Zhao, 1999). Vitamin D is generated from the oily secretions of skin into fur. The oral consumption of UV-exposed dermal excretion is the way many animals acquire the 'nutrient,' vitamin D. Although Fraser (1983) has argued that dermal absorption of vitamin D may be more natural, what we know from animals indicates that oral consumption is equally physiological. Since vitamin D can be extracted from UV-exposed human sweat and skin secretions (Bicknell and Prescott, 1946), it is also reasonable to think that early humans obtained some of their vitamin D by mouth as well, by licking the skin.
166. ^Yahav S, Buffenstein R (January 1993). 'Cholecalciferol supplementation alters gut function and improves digestibility in an underground inhabitant, the naked mole rat (Heterocephalus glaber), when fed on a carrot diet'. The British Journal of Nutrition. 69 (1): 233–41. doi:10.1079/BJN19930025. PMID8384476.
167. ^ ^abHolick MF (November 2005). 'The vitamin D epidemic and its health consequences'(PDF). The Journal of Nutrition. 135 (11): 2739S–48S. doi:10.1093/jn/135.11.2739S. PMID16251641. [Vitamin D3] is produced commercially by extracting 7-dehydrocholesterol from wool fat, followed by UVB irradiation and purification [...] [Vitamin D2] is commercially made by irradiating and then purifying the ergosterol extracted from yeast
168. ^Takeuchi A, Okano T, Sayamoto M, Sawamura S, Kobayashi T, Motosugi M, et al. (February 1986). 'Tissue distribution of 7-dehydrocholesterol, vitamin D3 and 25-hydroxyvitamin D3 in several species of fishes'. Journal of Nutritional Science and Vitaminology. 32 (1): 13–22. doi:10.3177/jnsv.32.13. PMID3012050.
169. ^ ^abcdAdams JS, Hewison M (February 2010). 'Update in vitamin D'. The Journal of Clinical Endocrinology and Metabolism. 95 (2): 471–8. doi:10.1210/jc.2009-1773. PMC2840860. PMID20133466.
170. ^ ^abcBikle DD (March 20, 2014). 'Vitamin D metabolism, mechanism of action, and clinical applications'. Chemistry & Biology. 21 (3): 319–29. doi:10.1016/j.chembiol.2013.12.016. PMC3968073. PMID24529992.
171. ^Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW (May 2004). 'Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase'. Proceedings of the National Academy of Sciences of the United States of America. 101 (20): 7711–5. Bibcode:2004PNAS..101.7711C. doi:10.1073/pnas.0402490101. PMC419671. PMID15128933.
172. ^Laing CJ, Cooke NE (2004). 'Section I: Ch. 8: Vitamin D Binding Protein'. In Feldman D, Glorieux FH, Pike JW (eds.). Vitamin D. 1 (2 ed.). Academic Press. pp. 117–134. ISBN978-0122526879.
173. ^'IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN): Nomenclature of vitamin D. Recommendations 1981'. European Journal of Biochemistry. 124 (2): 223–7. May 17, 1982. doi:10.1111/j.1432-1033.1982.tb06581.x. PMID7094913.
174. ^Holick MF, Kleiner-Bossaller A, Schnoes HK, Kasten PM, Boyle IT, DeLuca HF (October 1973). '1,24,25-Trihydroxyvitamin D3. A metabolite of vitamin D3 effective on intestine'. The Journal of Biological Chemistry. 248 (19): 6691–6. PMID4355503.
175. ^Horst RL, Reinhardt TA, Ramberg CF, Koszewski NJ, Napoli JL (July 1986). '24-Hydroxylation of 1,25-dihydroxyergocalciferol. An unambiguous deactivation process'. The Journal of Biological Chemistry. 261 (20): 9250–6. PMID3013880.
176. ^Carere S (July 25, 2007). 'Age-old children's disease back in force'. Toronto Star. Archived from the original on May 17, 2008. Retrieved August 24, 2010.
177. ^Conis E (July 24, 2006). 'Fortified foods took out rickets'. Los Angeles Times. Retrieved August 24, 2010.
178. ^McClean FC, Budy AM (January 28, 1964). 'Vitamin A, Vitamin D, Cartilage, Bones, and Teeth'. Vitamins and Hormones. 21. Academic Press. pp. 51–52. ISBN978-0-12-709821-0.
179. ^'History of Vitamin D'. University of California at Riverside. 2011. Retrieved May 9, 2014.
180. ^'Adolf Windaus – Biography'. Nobelprize.org. March 25, 2010. Retrieved March 25, 2010.
181. ^Rosenheim O, King H (1932). 'The Ring-system of sterols and bile acids. Part II'. J. Chem. Technol. Biotechnol. 51 (47): 954–7. doi:10.1002/jctb.5000514702.
182. ^Askew FA, Bourdillon RB, Bruce HM, Callow RK, St. L. Philpot J, Webster TA (1932). 'Crystalline Vitamin D'. Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character. 109 (764): 488–506. doi:10.1098/rspb.1932.0008. JSTOR81571.
183. ^Hirsch AL (2011). 'Industrial aspects of vitamin D'. In Feldman DJ, Pike JW, Adams JS (eds.). Vitamin D. London; Waltham, MA: Academic Press. p. 73. ISBN978-0-12-387035-3.
184. ^Ziedonis AA, Mowery DC, Nelson RR, Bhaven NS (2004). Ivory tower and industrial innovation: university-industry technology transfer before and after the Bayh-Dole Act in the United States. Stanford, Calif: Stanford Business Books. pp. 39–40. ISBN978-0-8047-4920-6.
185. ^Marshall J (September 2010). Elbridge a Stuart: Founder of Carnation Company. Kessinger Publishing. ISBN978-1-164-49678-6.
186. ^Haussler MR, Norman AW (January 1969). 'Chromosomal receptor for a vitamin D metabolite'. Proceedings of the National Academy of Sciences of the United States of America. 62 (1): 155–62. Bibcode:1969PNAS...62..155H. doi:10.1073/pnas.62.1.155. PMC285968. PMID5253652.
187. ^Holick MF, Schnoes HK, DeLuca HF (April 1971). 'Identification of 1,25-dihydroxycholecalciferol, a form of vitamin D3 metabolically active in the intestine'. Proceedings of the National Academy of Sciences of the United States of America. 68 (4): 803–4. Bibcode:1971PNAS...68..803H. doi:10.1073/pnas.68.4.803. PMC389047. PMID4323790.
188. ^Norman AW, Myrtle JF, Midgett RJ, Nowicki HG, Williams V, Popják G (July 1971). '1,25-dihydroxycholecalciferol: identification of the proposed active form of vitamin D3 in the intestine'. Science. 173 (3991): 51–4. Bibcode:1971Sci...173...51N. doi:10.1126/science.173.3991.51. PMID4325863.
189. ^Holick MF, DeLuca HF, Avioli LV (January 1972). 'Isolation and identification of 25-hydroxycholecalciferol from human plasma'. Archives of Internal Medicine. 129 (1): 56–61. doi:10.1001/archinte.1972.00320010060005. PMID4332591.
190. ^Dankers W, Colin EM, van Hamburg JP, Lubberts E (2016). 'Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential'. Front Immunol. 7: 697. doi:10.3389/fimmu.2016.00697. PMC5247472. PMID28163705.
191. ^ ^abHeaney RP, Holick MF (March 2011). 'Why the IOM recommendations for vitamin D are deficient'. Journal of Bone and Mineral Research. 26 (3): 455–7. doi:10.1002/jbmr.328. PMID21337617.
192. ^Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. (July 2011). 'Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline'. The Journal of Clinical Endocrinology and Metabolism. 96 (7): 1911–30. doi:10.1210/jc.2011-0385. PMID21646368.
193. ^'ODS Vitamin D Initiative'. Bethesda, MD: Office of Dietary Supplements, US National Institutes of Health. 2014.
194. ^Pyrżak B, Witkowska-Sędek E, Krajewska M, Demkow U, Kucharska AM (2015). 'Metabolic and immunological consequences of vitamin D deficiency in obese children'. Body Metabolism and Exercise. Advances in Experimental Medicine and Biology. 840. pp. 13–9. doi:10.1007/5584_2014_81. ISBN978-3-319-10249-8. PMID25315624.
195. ^'How is vitamin D being studied now in clinical cancer research?'. Bethesda, MD: National Cancer Institute, US National Institutes of Health. October 21, 2013.
196. ^Khan SU, Khan MU, Riaz H, Valavoor S, Zhao D, Vaughan L, et al. (July 9, 2019). 'Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes'. Annals of Internal Medicine. 171 (3): 190. doi:10.7326/m19-0341. ISSN0003-4819. PMID31284304.
197. ^Cashman KD, Dowling KG, Škrabáková Z, Gonzalez-Gross M, Valtueña J, De Henauw S, et al. (April 2016). 'Vitamin D deficiency in Europe: pandemic?'. The American Journal of Clinical Nutrition. 103 (4): 1033–44. doi:10.3945/ajcn.115.120873. PMC5527850. PMID26864360.
198. ^Sarkar FH, Li Y, Wang Z, Kong D (September 2010). 'The role of nutraceuticals in the regulation of Wnt and Hedgehog signaling in cancer'. Cancer Metastasis Reviews. 29 (3): 383–94. doi:10.1007/s10555-010-9233-4. PMC2974632. PMID20711635.

Further reading[edit]

D&d 3.5 Handbook Pdf

• NIH Vitamin D Fact Sheet for Health Professionals from the U.S. National Institutes of Health
• Disagreement among experts about the correct vitamin D dose. (Nature News, July 6, 2011)

External links[edit]

• Vitamin D in children from the Royal National Orthopaedic Hospital Trust

D& D 3.5 Geomancer Handbook Pdf

D And D 3.5 Players Handbook Pdf